Rosiglitazone mechanism of action is –
**Core Concept**
Rosiglitazone is a thiazolidinedione (TZD) class medication used in the treatment of type 2 diabetes mellitus. It works by activating specific nuclear receptors involved in glucose metabolism.
**Why the Correct Answer is Right**
Rosiglitazone acts by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), which regulates the expression of genes involved in glucose and lipid metabolism. This leads to increased insulin sensitivity in peripheral tissues, such as skeletal muscle and adipose tissue, thereby reducing fasting glucose levels and improving glycemic control. Additionally, rosiglitazone has been shown to decrease hepatic glucose production and increase glucose uptake in the muscles.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of rosiglitazone.
**Option B:** This option is incorrect because it refers to the mechanism of action of another class of diabetes medications, not thiazolidinediones.
**Option C:** This option is incorrect because it refers to the mechanism of action of a different type of medication altogether.
**Clinical Pearl / High-Yield Fact**
One key point to remember is that thiazolidinediones, like rosiglitazone, are associated with fluid retention and an increased risk of heart failure, which is an important consideration when prescribing these medications.
**Correct Answer:** C. Activation of PPAR-γ.